Mankind Pharma IPO — Listing Performance
Mankind Pharma IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 25 Apr 2023 |
| Listing date | 9 May 2023 |
| Issue price | ₹1,080 |
| Listing-day close | ₹1,422.30 (31.69%) |
| Recent market price | ₹2,280 (111.11% vs issue) |
| 52-week range | ₹1,716.55 – ₹2,660.60 |
| Identifiers | NSE: MANKIND · ISIN: INE634S01028 |
How the listing went
Mankind Pharma had a strong market debut, ending listing day 31.69% over the issue price.
Mankind Pharma against every other debut on record
- Rank in 2023: 71 of 172 NSE debuts, on a 31.69% first-day close.
- 64th percentile of 56 mainboard debuts in 2023 (median 21.06%).
- 5th of 6 debuts in May 2023.
- Opened 20.37% above issue, then added 11.32 points to the close.
- Day-one range ₹1,300 to ₹1,430: a 12.04% swing on the issue price.
- Last close ₹2,280 (11 Sep 2026): 111.11% above issue, against 31.69% on day one.
- 6% up its 52-week range of ₹1,716.55 to ₹2,660.60.
- Priced at the top of the ₹1,026 to ₹1,080 band.
- Listed 12 calendar days after close.
- All 508 mainboard debuts on record: median 12.01%, 72% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources